Literature DB >> 8554583

Streptokinase contains two independent plasminogen-binding sites.

D Nihalani1, G Sahni.   

Abstract

Streptokinase (SK) exerts its thrombolytic effect by activating plasminogen (PG) indirectly, after the formation of an equimolar complex with either PG or plasmin (PN). The location and nature of the PG/PN-binding sites in SK have been explored using limited proteolysis with immobilized trypsin. Employing Western blotting with radiolabeled PG after SDS-PAGE of total tryptic digest, three fragments of MW 7 kD, 19 kD and 31 kD were found to possess PG-binding ability. Each of these fragments was then isolated by reverse phase HPLC and characterised with respect to its sequence, as well as its PG-binding properties by ELISA. These analyses revealed that in addition to a PG-binding site in the region 143-293 reported recently in the literature, there is another distinct, high-affinity and independent PG-binding site, located in the N-terminal region (residues 1-59) of SK. Using a synthetic peptide, the N-terminally located PG-binding-site has been further localised to the region 37-51 of SK. Further, we demonstrate that the PG-binding of this peptide is not mediated through the lysine-binding sites ("Kringles") of PG. This stretch contains a short sequence (LTSRPA) that is also present in the PG-binding domain of human fibronectin.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8554583     DOI: 10.1006/bbrc.1995.2902

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  7 in total

1.  Identification through combinatorial random and rational mutagenesis of a substrate-interacting exosite in the gamma domain of streptokinase.

Authors:  Suman Yadav; Rachna Aneja; Prakash Kumar; Manish Datt; Sonali Sinha; Girish Sahni
Journal:  J Biol Chem       Date:  2010-12-17       Impact factor: 5.157

2.  Function of the central domain of streptokinase in substrate plasminogen docking and processing revealed by site-directed mutagenesis.

Authors:  A Chaudhary; S Vasudha; K Rajagopal; S S Komath; N Garg; M Yadav; S C Mande; G Sahni
Journal:  Protein Sci       Date:  1999-12       Impact factor: 6.725

Review 3.  Streptokinase--the drug of choice for thrombolytic therapy.

Authors:  Adinarayana Kunamneni; Thaer Taleb Abed Abdelghani; Poluri Ellaiah
Journal:  J Thromb Thrombolysis       Date:  2007-02       Impact factor: 2.300

4.  The evolution of recombinant thrombolytics: Current status and future directions.

Authors:  Yogender Pal Khasa
Journal:  Bioengineered       Date:  2016-10-03       Impact factor: 3.269

5.  Mapping of the plasminogen binding site of streptokinase with short synthetic peptides.

Authors:  D Nihalani; G P Raghava; G Sahni
Journal:  Protein Sci       Date:  1997-06       Impact factor: 6.725

6.  Engineering of plasmin-resistant forms of streptokinase and their production in Bacillus subtilis: streptokinase with longer functional half-life.

Authors:  X C Wu; R Ye; Y Duan; S L Wong
Journal:  Appl Environ Microbiol       Date:  1998-03       Impact factor: 4.792

7.  Analysis of the interactions between streptokinase domains and human plasminogen.

Authors:  F Conejero-Lara; J Parrado; A I Azuaga; C M Dobson; C P Ponting
Journal:  Protein Sci       Date:  1998-10       Impact factor: 6.725

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.